Alps Advisors Inc Pacira Bio Sciences, Inc. Transaction History

Alps Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 04, 2019	SELL	$41.31 - $52.16 $2.99 Million - $3.78 Million	-72,484 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$32.85 - $52.0 $439,204 - $695,240	13,370 Added 22.62%	72,484 $3.56 Million
Q2 2018 Aug 02, 2018	BUY	$27.5 - $39.8 $389,345 - $563,488	14,158 Added 31.49%	59,114 $1.9 Million
Q2 2018 Jul 25, 2018	SELL	$27.5 - $39.8 $260,067 - $376,388	-9,457 Reduced 17.38%	44,956 $2.05 Million
Q1 2018 May 01, 2018	BUY	$29.98 - $46.35 $283,520 - $438,331	9,457 Added 21.04%	54,413 $1.7 Million
Q4 2017 Feb 05, 2018	BUY	$31.85 - $46.95 $166,416 - $245,313	5,225 Added 13.15%	44,956 $2.05 Million
Q3 2017 Nov 03, 2017	BUY	$35.7 - $39.5 $1.42 Million - $1.57 Million	39,731	39,731 $1.49 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.